Investor Presentation • Aug 19, 2021
Investor Presentation
Open in ViewerOpens in native device viewer
Luc Dionne, CEO Tekna Holding AS
August 19, 2021
Total Revenues CAD 7.4 million 95% growth from Q2 2020
Adjusted EBITDA CAD -1.1 million CAD 0.9m decrease from Q2 2020
Recurring Materials revenues
CAD 3.5 million 84% growth from Q2 2020
Materials revenues1
CAD 5.0 million
103% growth from Q2 2020
1 Includes tolling services 2
Sources: SmarTech – 3D Printing and Additive Manufacturing reports, Wohlers Associates – 3D Printing and Additive Manufacturing Global State of the Industry, ARK Investment management – Big Ideas 2021, Cairn Energy Research Advisors – SI Marketscape and opportunities, company estimates
| Customer | ountry ပ |
ACCOUNT QUALIFICATION |
PRODUCT QUALIFICATION | MANUFACTURING PRE-PROD. QUALIFICATION APPROVAL |
QUOTE PROCESS & CONTRACT NEGOTIATION |
Score Total |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK | $2H22$ 25 | ||||||||||||||||||
| SK | $2H22$ 25 | ||||||||||||||||||
| 3 | JPN | $2H22$ 25 | |||||||||||||||||
| 4 | JPN | $2H22$ 25 | |||||||||||||||||
| 5 | JPN | TBD | 22 | ||||||||||||||||
| 6 | JPN | 1H23 16 | |||||||||||||||||
| JPN | $1H23$ 14 | ||||||||||||||||||
| 8 | JPN | TBD | 8 | ||||||||||||||||
| 9 | JPN | TBD | 8 | ||||||||||||||||
| 10 | SK | TBD | $\overline{2}$ |
Completed On-going Closed
Partnership with LG Chem developing positively Research milestone expected in Q4 2021
| 1 Financial highlights (CADm) |
2021 Q2 |
2020 Q2 |
2021 YTD |
2020 YTD |
2020 FY |
|---|---|---|---|---|---|
| Revenue | 7.4 | 3.8 | 15.2 | 8.1 | 22 |
| Gross Margin 2 |
46% | 53% | 48% | 49% | 3 49% |
| 2 Adjusted EBITDA |
-1.1 | -0.2 | -0.8 | -1.9 | 1.4 |
| Adjusted EBITDA % |
-15% | -5% | -5% | -23% | 6% |
| EBITDA | -1.2 | -0.2 | -1.5 | -1.9 | 1.4 |
| EBITDA % | -16% | -5% | -10% | -23% | 6% |
| Cash balance at the end of the period | 45.7 | 2.1 | 45.7 | 2.1 | 2.5 |
| Recurring revenue (% of materials revenue) |
86% | 80% | 82% | na | na |
1 The figures have been prepared in accordance with IFRS
2 EBITDA adjusted for non-recurring items
3 2020 adjusted EBITDA includes CAD 2.7m in the form of grants for Covid mitigation, as well as CAD 3.6m
of commercial rights and OPEX recharge to the JV Imphytek powders in Q4
| 3D printing | ON TARGET ✓ 8% market share forecast and \$22m annual run rate revenue by YE2021 • Performance indicators are all green for AM powder revenues ✓ \$2.5bn market size and 24% market share growth projection maintained • Strong demand with increasing customer base and average order size • Market position is improving with long-term supply agreements |
|
|---|---|---|
| Printed electronics | ON SCHEDULE ✓ 2021 material validation and order intake targeted in H2 2022 • Demand for evaluation of Tekna ultra-fine nickel powder has increased in 2021 • \$1bn market size and 35% market share target could be favorably revised in 2022 ✓ Demand for EVs and 5G mobility is growing massively • Selling price of ultra-fine nickel powder is expected to stay high |
|
| Energy storage | FULL SPEED AHEAD ✓ Industrialization plan and powder development effort • Electrification of transport & green power are fueling demand for energy storage ✓ \$34bn market size and 3% market share targets are holding course • LG Chem JDA secured, Silicon samples and system design are on-going • Tekna's ranks 1st and 2nd on impact on energy density and scale-up potential |
The ideal position in the value chain is one where Tekna brings the most value to the customers, while increasing market share and revenue
Reducing environmental footprint
E S G
• ESG report 2021
All (production) facilities powered by clean energy in Canada (hydro)
| Metric | 2021 | Mid-to-long term ambition |
|---|---|---|
| Revenue growth | Reach CAD 22M run-rate materials sales during 2021 |
40-50% organic revenue growth per year |
| Business mix | ~50% AM, ~35% SY, ~15% other | Mid-term: ~30% AM, ~20% PE, ~25% ES, ~15% SY + other Long-term: ~50% ES, ~25% AM, ~15% PE, 10% SY + other |
| Operational EBITDA margin1 |
Below break-even | Towards 25% mid- and long-term |
| R&D | 5% of revenues near-term Towards 3% mid-to long-term |
|
| Growth capex | Expansion within existing facilities | Targeting 30+ plasma units in operation by 2025, 250+ plasma units in operation by 2030 |
| Other capex | Maintenance capex >1% of revenues |
The Q2 performance is in line with our expectations
The market indicators we are monitoring are positive We reiterate our near- and long-term targets
2
| CADm | 2021 Q2 |
2020 Q2 |
2021 YTD |
2020 YTD |
FY 2020 |
|---|---|---|---|---|---|
| Revenue | 7.4 | 3.8 | 15.2 | 8.1 | 22,0 |
| Cost of sales1 | 4.0 | 1.8 | 7.9 | 4.1 | 11.3 |
| Gross margin | 3.4 | 2.0 | 7.3 | 4.0 | 10.7 |
| Gross margin % | 46% | 53% | 48% | 49% | 49% |
| Other income | -0.2 | -1.7 | -0.2 | -1.7 | -4.22 |
| Indirect personnel expenses | 3.4 | 2.7 | 6.1 | 5.3 | 10.6 |
| Other OPEX | 1.3 | 1.2 | 2.2 | 2.3 | 2.93 |
| Total other income and OPEX | 4.5 | 2.2 | 8.1 | 5.9 | 9.3 |
| Adjusted EBITDA | -1.1 | -0.2 | -0.8 | -1.9 | 1.4 |
| Adjusted EBITDA margin % | -15% | -5% | -5% | -23% | 6% |
| Non-recurring expenses | 0.1 | 0.7 | |||
| EBITDA | -1.2 | -0.2 | -1.5 | -1.9 | 1.4 |
| EBITDA margin % | -16% | -5% | -10% | -23% | 6% |
| Depreciation and amortization | 0.8 | 1.0 | 1.6 | 1.9 | 3.94 |
| EBIT | -2.0 | -1.2 | -3.1 | -3.8 | -2.5 |
| EBIT margin % | -27% | -32% | -20% | -47% | -11% |
| Equity company loss (income) | 0.4 | 0.7 | 2.0 | ||
| FX variation (Gain) Loss | -1.0 | -1.0 | |||
| Finance cost | 0.3 | 0.3 | 0.6 | 0.7 | 1.4 |
| EBT | -1.7 | -1.5 | -3.4 | -4.5 | -5.9 |
| Provision for income tax | -0.1 | -0.4 | -0.1 | -0.9 | -1.14 |
| Net profit/loss | -1.6 | -1.1 | -3.3 | -3.6 | -4.8 |
2020 OPEX costs include a CAD 2.0m recharge in Q4 to the JV
Decrease of CAD 1.0m in amortization of intangibles and CAD 1.5m in tax expense have been recorded following the formal evaluation of the Purchase price allocation of 2013.
| Balance sheet | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CADm | 30.06.2021 | 31.03.2021 | 31.12.2020 | 30.06.2020 | ||||||
| ASSETS | ||||||||||
| Deferred tax assets | - | 1.5 | ||||||||
| Other intangible assets | 9.8 | 9.3 | 9.4 | 11.4 | ||||||
| Tangible fixed assets | 18.8 | 18.4 | 18.1 | 16.6 | ||||||
| Investment in equity companies | 0.7 | 1.1 | 1.4 | |||||||
| Other long-term receivables | 5.5 | 5.5 | 4.2 | 4.1 | ||||||
| Total non-current assets | 34.8 | 34.3 | 33.1 | 33.6 | ||||||
| Inventory | 13.0 | 13.0 | 12.0 | 14.3 | ||||||
| Contract assets | 2.4 | 1.4 | 0.5 | |||||||
| Accounts receivable and other receivables | 7.0 | 7.9 | 5.8 | 4.7 | ||||||
| Cash and cash equivalents | 45.7 | 102.1 | 2.5 | 2.1 | ||||||
| Total current assets | 68.1 | 124.4 | 20.8 | 21.1 | ||||||
| Total assets | 102.9 | 158.7 | 53.9 | 54.7 |
For presentation purposes, adjustments were made to the Intangible assets following the formal evaluation of the Purchase price allocation of 2013. The intangible assets were increased by CAD 0.5m as of 30.06.2020, by CAD 1.0m as of 31.12.2020 andCAD 1.2m as of 31.03.2021
For presentation purposes, adjustments were made to the Deferred tax liabilities following the formal evaluation of the Purchase price allocation of 2013. The Deferredtax liabilities were increased by CAD 1.4m as of 30.06.2020
| Balance sheet | ||||
|---|---|---|---|---|
| CADm | 30.06.2021 | 31.03.2021 | 31.12.2020 | 30.06.2020 |
| LIABILITIES AND EQUITY | ||||
| Owners' equity | 88.2 | 87.1 | 20.1 | 1.2 |
| Minority interest | 0.6 | 0.7 | 0.0 | |
| Total equity | 88.8 | 87.8 | 20.1 | 1.2 |
| Deferred tax liabilities | 3.3 | |||
| Leasing obligations | 0.4 | 0.4 | 0.5 | 0.6 |
| Other long-term debt | 3.8 | 30.6 | 24.2 | 41.4 |
| Total non-current liabilities | 4.2 | 31.0 | 24.7 | 45.3 |
| Current interest-bearing borrowings | 3.0 | 3.8 | 0.7 | 2.8 |
| Current interest-bearing liabilities | 23.6 | - | ||
| Accounts payable | 3.4 | 9.7 | 4.3 | 3.2 |
| Leasing obligations | 0.2 | 0.2 | 0.2 | 0.2 |
| Other current liabilities | 3.3 | 2.6 | 3.9 | 2.0 |
| Total current liabilities | 9.9 | 39.9 | 9.1 | 8.2 |
| Total liabilities and equity | 102.9 | 158.7 | 53.9 | 54.7 |
CASH FLOW
| Cash flow | 2021 | 2021 | 2020 |
|---|---|---|---|
| CADm | Q2 | Q1 | Q2 |
| Net profit | -1.6 | -1.7 | -1.1 |
| Depreciation and Amortization | 0.8 | 0.8 | 1.0 |
| Tax expense | -0.4 | ||
| Net financial items and Fx variation |
-0.6 | 0.3 | 0.3 |
| Change in inventory, contract assets, receivables, payables and other liabilities | -0.9 | -4.6 | -2.8 |
| Share of profit from associates | 0.4 | 0.3 | |
| Net cash from operations |
-1.9 | -4.9 | -3.0 |
| Purchase of PPE and intangible assets | -1.7 | -1.0 | -1.4 |
| OtherInvestments activities | -1.3 | -0.1 | |
| Purchase of shares in subsidiaries | 0.2 | -23.7 | |
| Net cash from investing activities | -1.5 | -26.0 | -1.5 |
| Cashflow from issuance of stock | -1.2 | 96.8 | |
| Proceeds from the issuance of shares in subsidiary | 1.3 | ||
| New long -term borrowings |
0.1 | 0.1 | 0.1 |
| Repayment of long -term borrowings |
-0.1 | -0.1 | -0.1 |
| Internal loans and borrowings |
-50.4 | 30.1 | 3.6 |
| Net change in current interest -bearing debt |
-0.8 | 3.1 | -0.4 |
| Interest paid | -0.2 | -0.2 | -0.3 |
| Net cash from financing activities | -52.6 | 131.1 | 2.9 |
| Cash flow | -56.0 | 100.2 | -1.6 |
| FX adjustments | -0.4 | -0.6 | |
| Change in cash and cash equivalents | -56.4 | 99.6 | -1.6 |
| Opening Balance for Cash assets | 102.1 | 2.5 | 3.7 |
| Closing Balance for Cash assets | 45.7 | 102.1 | 2.1 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.